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I. Background of research and justification of the project 
 
Why does a tiny – molecular-level – laboratory result trigger global economic, social 
and political changes? By transforming cells and molecules and transplanting genes from one 
organism into another, biotechnology is not a simple innovation that leads to a new product or 
reengineers a production process. Its spill-over effect rearranges entire industries, creates new 
activities, may transform our consumption habits, creates new power positions or reinterprets 
important basic concepts – just to mention a few important implications. It generates 
fundamental and radical changes. And it follows from all this that it is a highly controversial 
field.. 
Every new product, technology or organization has to create its acceptance and 
legitimacy – it has to find its place in the existing socio-economic and cultural context, 
whereby it also influences it. What I seek to understand in my Ph.D. research is what actors 
are involved, and how, in the debate around agricultural biotechnology and in shaping the 
economic and social legitimacy of the products of this field. 
In the light of the foregoing, my research questions are, therefore, as follows:  
1. What stakeholder groups’ activities shape agricultural biotechnology: Who are the 
players  and active participants of what is known as the organizational field of agricultural 
biotechnology?  What actors take part in the legitimization (or de-legitimization) process?     
2. In other words, how do the stakeholders shape the economic and social acceptance 
and legitimacy of agricultural biotechnology? What arsenal of legitimization tools, arguments 
and ultimately strategy do they use to establish the legitimacy of or, on the contrary, to 
delegitimize agricultural biotechnology?   
In my research I aim at determining the domestic field of agricultural biotechnology. I 
wish to map the range of actors participating in this legitimization (or de-legitimization) 
process and what legitimising arguments they use. Overall, I would, therefore, like to 
understand the dynamics of the institutional and organizational field where the social 
legitimacy of agricultural biotechnology is constituted and constructed. 
By choosing my theme I intended to explore the literature of legitimacy and its place 
in organizational studies. The subject of legitimacy is, in my opinion, overshadowed by 
studies of companies’ and industries’ competitiveness, whereas market behaviours are 
difficult to make sense of without clarifying the socio-economic and political embeddedness 
of companies and industries. That is particularly true of emerging industries, new products 
and technologies, where embeddedness and the establishment of legitimacy is the primary 
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task. My research is directed at the field of agricultural biotechnology, and within that, plant 
biotechnology. Therefore, it does not cover but, inevitably, touches on the pharmaceutical and 
biomedical aspects of biotechnology as well as its linkages to the chemical, environmental 
and other industries. In other words, I conduct my research in what is commonly referred to as 
green biotechnology leaving aside the fields of red (medical, pharmaceutical and diagnostic) 
and white (industrial and environmental) biotechnology. 
In 2011, genetically modified crops were grown on 160m hectares in 29 countries 
[James, 20121]. The United States (69m ha), Brazil (30.3m ha) and Argentina (29.7m ha) are 
considered the biggest producers, so much so that over three quarters of the world’s total land 
area used for growing GM crops are in these three countries. The primary crops are transgenic 
soybeans, corn and cotton, but e.g. in the United States, in addition to these crops and the 
previously mentioned rapeseed, alfalfa, sugar beet, papaya, squash, zucchini and tobacco. In 
addition to these production data it is known that many countries and regions explicitly 
prohibit the use of genetically modified seeds. In the EU Austria, Bulgaria, France, Greece, 
Poland, Luxembourg, Hungary have use the option of what is known as safeguard clauses, 
thus ban the import and application of GM seeds. 
The dissertation, looks at the interpretations of legitimacy by the relevant schools of 
thought of organizational theory. In clarifying the concept, I draw on Suchman’s [1995] 
legitimacy typology in an effort to identify the different dimensions of legitimacy. Then, 
industries affected by agri-biotechnology are introduced, and two tendencies providing 
fundamental contributions to legitimacy are presented. Strategic alliances and integration and 
concentration processes induced in particular industries serve as a basis for associative 
legitimacy. Methodological background, considerations and process of the empirical research 
are coverd in details. The results of the three pillars of the research – interviews with 
members of the organizational field, researchers’ media debates and consumer focus group 
discussions – are presented  
The unique feature of the research lies in its resting on multiple methodological pillars 
in addition to its organizational-theory-based perspective. Therefore, it is characterised not 
only by the pluralism of data collection methods and their matching with particular 
stakeholder groups, but also by its coverage of the widest possible range of stakeholders. 
I.1. Legitimacy in organizational theory  
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The key term of this dissertation is legitimacy. Obviously, it is a concept deprived of 
values. If anything or anyone is deemed legitimate, it expresses that it has been accepted or 
the relevance of the matters has been confirmed. On the contrary, if anything or anyone is not 
deemed legitimate, that reflects a severe verdict. Deprivation of legitimacy is doubting of 
relevance. Consequently, for organizations it is a crucial issue to become legitimate parts of a 
particular community, where a particular action or the lawfulness of their operation is not 
doubted. Consequently, legitimacy is an important concept both in organizational science and 
in corporate management practice. 
Suchman [1995] provides a comprehensive review and architectonic typology of the 
term “legitimacy” used in organization and management studies. He offers the following 
definition of legitimacy, covering all organization theoretical schools: 
„ Legitimacy is a generalized perception or assumption that the actions of an entity are 
desirable, proper, or appropriate within some socially constructed system of norms, values, 
beliefs, and definitions.” [Suchman, 1995:574]2 
In structure, I follow the dual distinction of the literature, which points to the separate 
traditions of the institutional, the strategic and the discursive approach. In the analysis of 
legitimacy, the institutional approach focuses on external (i.e., extra-organizational) 
institutional structures. “They look from outside to inside” (from the external institutional 
environment into the organization), and check whether or not the organization complies with 
the set of rules, norms, values and convictions institutionalised in a particular social 
environment. On the contrary, strategic approaches turn adopt the inverse perspective and 
“look from inside to the outside”. The main representatives of the organization apply strategic 
analyses and identify the most important external actors representing survival or prosperity 
for the organization, and they try to manage the organization based on the interests, values 
and expectations (or affecting the perceptions) of those actors). Consequently, the strategic 
approach focuses on the potential agency. In this situation, the organization is not a passively 
adjusting party, like in the institutional approaches. 
Suchman’s review work is used as a common framework in the dissertation. Three 
categories of organizational legitimacy are distinguished: pragmatic, moral and cognitive 
legitimacy. According to his statement, these are differentiated through the fact that they are 
based on different behavioural patterns. Pragmatic legitimacy is based on the short-term, self-
                                                 
2
 “Legitimacy is a generalized perception or assumption that the actions of an entity are desirable, proper, or 
appropriate within some socially constructed system of norms, values, beliefs, and definitions.” [Suchman, 
1995:574] 
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interested calculations of the stakeholders.  Moral legitimacy is not based on what is called 
pro-social behavioural forms. Moral legitimacy refers to the favourable normative judgement 
of the given organization and/or its activities on the side of the stakeholders The cognition-
based legitimacy dynamism refers to the fact that the organization or the industry is a 
necessary, not questioned, predictable part of the given cultural reality, which can clearly be 
interpreted by everybody.   
Suchman’s typology does not refer to any other level. However, some schools of 
organizational theory pay attention to the broader macro level, thus socio-political legitimacy 
is brought to the forefront. The next table describes which dimensions of legitimacy is 
discussed the given approaches. 
Table 1 Types of legitimacies in organizational studies 
Organizational study Characteristic type of legitimacy 
Strategic 
     Resource-dependency theory pragmatic 
     Stakeholder theory moral 
     Non-market and collective strats pragmatic 
Institutional 
     Sociological instititutional pragmatic, moral, cognitive 
     Population ecology pragmatic,                     
socio-political 
Discursíve pragmatic, moral, cognitive 
socio-political 
Sources: Author’s compilation 
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I.2 The biotechnology community 
 
According to relevant literature, the establishment of interorganisational relations is an 
emphatic tool of creating legitimacy. Activities done within the economy, on the market and 
within company boundaries – that is, not only at abstract research institutes and mystical 
laboratories anymore – gain the partnership of the economy’s and the market’s accepted, 
mature players. These connections are spectacular and visible, thus they make the biotech 
firm easily recognisable to further participants, in other words, they cast light upon its 
existence. 
In my study the term biotech industry refers merely to biotechnological firms, it does 
not contain other industrial areas “fertilised” by biotechnology. Considering the definition 
given by one of the leading industrial organisations, Biotechnology Industry Organization 
(BIO), companies whose “primary activity is to apply cellular and molecular processes in 
order to manufacture products and solve problems belong to this industry…for example large 
pharmaceutical firms do not belong here” (BIO, 2000). In turn, others would extend the 
industry’s boundaries to further enterprises: although they do not regard large multinational 
companies and conglomerates as part of the industry either, but they approve of businesses 
established explicitly in the wake of biotech firms, such as biotechnologically orientated 
venture capital corporations, legal firms specifying in relevant patents and licences as well as 
intellectual property rights (see Powell et al, 2005 a.o.). The participation of the latter – claim 
Barley, Freeman and Hybels (1992) – does not result in an industry but a biotech community. 
The process of intertwining in the biotechnology community can be observed in the 
following main transformations: 
• horizontal integration: biotechnology, as a new technology penetrating 
numerous industries, accelerated the intertwining of these industries.3  
• vertical integration: in order for the technology to turn into products, the 
participants of the supply chain became interrelated through mergers and acquisitions. 
• strategic alliances, networks: innovative biotechnology enterprises involving 
the new technology and know-how induced cooperations that coordinate the biotech 
community in a multiple way. 
 
                                                 
3
 An example for this: in order to demonstrate the interrelation of the two involved industries, the CEO of a large 
company focusing on agri-biotechnology drew a parallel between an envelope and the sowing seed, as well as a 
letter and biotechnology, where the envelope delivers the letter (Bijman, 2001).  
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Figure 1: Biotechnological industry, community, organisational field4 
 
Source: Edited by the author 
 
Alliance relations also automatically endow biotech firms with associate legitimacy. 
The honour that surrounds legitimate and accepted partners within the alliance is cast onto 
new participants (legitimacy spillover); the mature company gives biotech firms a share of its 
experience-related privileges, and as a reference it promotes their embedding as well as the 
establishment of their own legitimacy. 
 
                                                 
4
 Major participants. The figure does not contain all relations due to transparency limitations. The size of 
participants in the figure does not reflect their real size, weight etc. The relations are relevant and important 




































II. The main characteristics of the empirical research  
The set of legitimacy arguments relating to agricultural biotechnology in Hungary are 
analysed in my Ph.D. research. I am trying to describe the development of this industry, in the 
crossfire of discussions, which is partly creating its products at the moment, and partly trading 
them already with a huge profit in many places. The purpose of the research is hence to 
disclose and understand the relevant drivers, activities and strategies in Hungary that focus on 
the establishment of the social legitimacy of this emerging industry 
I am aiming at answering the following research questions: 
1. What stakeholder groups’ activities shape agricultural biotechnology: Who are the 
players  and active participants of what is known as the organizational field of agricultural 
biotechnology?  What actors take part in the legitimization (or de-legitimization) process?     
2. In other words, how do the stakeholders shape the economic and social acceptance 
and legitimacy of agricultural biotechnology? What arsenal of legitimization tools, arguments 
and ultimately strategy do they use to establish the legitimacy of or, on the contrary, to 
delegitimize agricultural biotechnology?   
A three-pillar research plan was designed: semi-structured interviews, the analysis of 
researcher media debates and focus group discussions with consumers, based on a grounded 
theory and critical discourse analysis. Table 2 provides information about the 3 distinc pillars 
of the research. 
Table 2..  Applied data collection tools 
Research tool Years Purpose of research 
Relevant members 












to identify the 
arguments and 













to identify consumer 












to identify the 
arguments of 




Source: Author’s compilation 
A qualitative exploratory piece of research is aimed at answering the research 
questions underpinned by grounded theory and critical discourse analysis as a methodological 
basis.  
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III Legitimacy strategies 
Features of the organisational field, active stakeholders were identified, legitimation 
activities and argumentation were explored and compared to research findings of earlier 
Hungarian studies.  
III:1 Coporate strategies 
 
Two different approaches are discernible in their representation of biotechnology and their 
identification with it, which can be distinguished first and foremost on the  basis of the range 
of stakeholder groups with which they communicate and their communication channels. 
These two key features are concurrent with other criteria like the mode of interaction (uni- or 
bidirectional communication), the representation of the biotechnology issue within the 
organisation (whether it has a dedicated representative, expert(s) specifically assigned to it at 
the subsidiary). The two main approaches are the following: 
1. it does not handle the biotechnology issue independently, but through the channels of 
the parent company, the industry organisation etc.; 
2. it applies a diversified communication toolkit for all stakeholders (authorities, 
farmers) other than the food consumers; active, public participation (in addition to the 
foregoing: media presence, utterances at public fora). 
The argument for inter-company cooperation is that as long as the objective is not a 
specific product, and the underlying market share but the promotion of GMOs in general, 
such cooperation is welcome. It could be outright advantageous for companies that prefer not 
to have their names publicly associated with GMO. Thus it can operate in the shelter of a 
louder and more assertive association or company hoping for favourable developments. 
Companies choosing to play that role emphasise that GMO for them is not a last resort, not a 
forced path to follow. They can meet their clients’ demand by their traditional products, and 
they have no major biotechnological investment behind them waiting to bring its financial 
return that should critically force them to enter the GMO segment. At the same time, 
however, the question also emerges – though with varying intensity – if their local market, 
their local relationships, local acceptance – and ultimately their legitimacy – will not suffer if 
the ‘shadow of GMO’ is cast over them. Thus at the same time they also try to minimise their 
expenses and risks in this struggle for legitimacy in which the wait-and-see strategy seems 
appropriate. 
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The corporate members of the organisational field feature each of the strategies and 
tactics of influencing legitimacy listed in table 3. Even with active players the conformity 
strategy is the most powerful, although one must note that, by its nature, this is the most 
visible, and the most public option for creating acceptance. ‘We [i.e. people in decision 
making, or decision preparing position] wish to be good friends with everyone’ – that is the 
intention at a verbal level, and, once converted into action, it means that they inform the 
decision maker of the corporate view/results, and help him familiarise with or study the 
subject.  
The strategy of conformity is reflected – in addition to offering the outcome of 
corporate research to the community – also by their statement whereby genetic modification 
is the natural continuation of plant improvement (cf. chapter 6). One may list here also the 
arguments aimed at dismissing doubts of dominance/power. An argument of this type is that 
GMOs help multinationals become the predominant actors of agriculture. The retort to this 
suggestion is embarrassingly simple: all the companies concerned have been present in 
Hungary for at least a decade, and have built up a major market share, so there is no change 
that GMO could bring about. Employing the argument of ‘economic competitiveness’ in the 
context of Hungarian institutions is aimed at conformity, and represents the tactic of imitation 
(for more detail see chapter 6).  
The reconciliatory tactic of the compromise strategy is the use of environmentally 
friendly arguments. An example of the strategy of avoidance is the fending behaviour 
experienced by a Hungarian institution that requested sowing seed from the American head 
office for research purposes. The response was flat refusal saying ‘that would be too early for 
you’. Some companies eventually exit the market, or e.g. they give up conducting open-field 
experiments, or, in overlap with another strategy: control/manipulation a company calls off its 
Hungarian lobbying, and relocates it to Brussels perhaps along with their entire local team. 
With the only exception of Monsanto, the method of avoidance/concealment whereby they 
just refuse to admit it publicly, and stay away from the media with this subject is generally 
practised. An exciting amalgamation of conformity and opposition is when, in addition to 
‘wishing to be friends’ they raise a question mark, and start suggesting the incompetence of 
the relevant policymakers.  
The companies themselves, and, even more so other groups involved, primarily list 
legitimising activities that fit the strategy of manipulation. ‘Monsanto used to sit around here 
week after week’ an official from a regulatory authority said evaluating the company’s 
ministerial lobbying as a kind of tiring-out exercise. The tactics of co-opting is useful to 
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create research relationships, and, through that, a special piece of legitimacy built on scientific 
prestige. 
Although environmental considerations have occurred also in corporate 
argumentation, the topic of sustainability has not been raised. There were not even references 
to sustainability either in connection with the companies or with agriculture – responsible, 
sustainable company operation, sustainable agricultural production – through any channel. 
That is, this topic was missing from the press appearances of the companies, and also from the 
interviews conducted for this research, whereas it has been present to an increasing extent in 
the international debates and arguments concerning agro-biotechnology, incorporating also its 
environmental-ecological, social and economic aspects. With CSR (corporate social 
responsibility) becoming a fashionable topic, however, a certain change has been experienced 
in Hungary. In connection with CSR, most of the companies concerned speak in the 
overwhelming majority of cases of activities and developments incorporated in specific action 
(donation, volunteering, collection of employee ideas for the same, material- and energy-
saving at the office or in the context of travel). Within that, only a most narrow group presents 
such programmes – mostly deriving mainly from the international background of the 
company – that are in direct correlation with the core activity (seed donation, scholarship 
programme, avoidance of damage caused by agriculture, soil and water protection 
programmes, joint research to preserve the biological diversity of agricultural areas). 
 
III.2. Reserchers’ discourses 
 
Media representations of agricultural biotechnology represent a popular area of 
research where studies are primarily focussed on collecting and analysing press publications. 
Although some of them contain a certain pre-selection in respect of contents (themes, cited 
actors, etc.), the key criterion of selecting writings for analysis is the place of release. The 
current research fundamentally departs from that method of choosing its area of focus  in 
almost every respect. At the same time, these media research projects –those focusing on both 
the international and domestic press – can provide an important backdrop and reference points 
for the analysis of researchers’ debates covered by the domestic printed media. 
In the past somewhat more than a decade we witnessed researcher debates on 
agricultural biotechnology in the domestic press almost annually. I do not mean scientific 
communications published in science journals, but articles written for the purpose of 
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awareness raising, addressing either the researcher community or the general public, often in 
the genre of (political) journalism, reflecting on one another. 
It is no exaggeration to say that researchers’ media debates have created a rhetorical 
battlefield in the discussion of genetically modified plants. My analysis has revealed six 
argumentation strategies to obtain and/or destro:: labelling, exclusion, favourable 
comparisons, decoupling, down-playing., and argumentative crossovers. Two narratives have 
been developed: Pusztai-case, an emblematic narrative also about what is science, and 
competetivness, which is actually beyond the professional sope of the natural scientists 
involde int he media debats.  
The analysis of the researchers’ media debates supplied information on the debate 
concerning scientific knowledge. As we could see under the argumentation strategy of 
exclusion, the researchers assign each other to the categories of (scientifically) “acceptable” 
and “unacceptable” based on their opinions expressed on genetic modification and its current 
results. 
III.3. Consumers’ perception 
 
Based on a detailed overview of local and international research on consumers’ 
knowledge about and attitude to GMO, 4 focus group discussions were organized. 
Participants of average income and with Budapest residence were expected it was considered 
important to involve in the discussion persons who were active decision makers, and 
participants in shopping food for the family / household, and media consumers at the same 
time.  
It has been clearly and predominantly concluded from international and domestic 
consumer surveys that most European and Hungarian consumers reject agricultural 
biotechnology. Domestic consumers are particularly dismissive of agricultural GM products 
even in the European context, and make clearly negative associations with such products  
Consumers who are not in command of in-depth scientific knowledge are 
characterised by being reflexive on their lack of knowledge, that is, they know what they do 
not know, i.e. what they would like to obtain information on to overcome their painful lack of 
knowledge. Furthermore, they are characterised by some kind of heuristic knowledge about 
the already quite complex foodstuffs and institutional system. 
The participants expressed their lack of trust in every actor of the organisational field 
mentioned in the discussions. 
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As shown in each of pillar of the empirical research, knowledge is a significant topos 
for every stakeholder group. The most prominent features emerging from the interviews are 
the following: doubts concerning the knowledge and competencies of policy-makers and of 
the competent ministry staff; superficial knowledge of laymen environmental and consumer 
protection activists – and, the most forceful one: correlation between the knowledge and 
results of researchers and their independent researcher status.  
 
IV. Research findings 
Even though pragmatic legitimation of GMO seed is non-existent in Hungary due to 
the ban on GMOs, in the argumentation around these products one can come across with it. 
Not only this dimension, but the other two aspects involved in Suchman’s typology proved to 
be appropriate in understanding and evaluating new products. An added level is need though. 
In harmony with the considerations of the institutional and the discursive approaches the 
socio-political dimension of legitimacy was highlighted here. 



























Source: Author’s compilation 
 
The thesis examined the legitimation and de-legitimation strategies applied by 
members of the Hungarian organisational field of agro-biotechnology in regard of genetically 
modified plants. First I reviewed and systemised the legitimacy interpretations of the various 
approaches of organisational theory. I processed the strategic, sociological institutional and 
discursive approaches, respectively, according to the same legitimacy typology, and I placed 
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pragmatic, moral and cognitive legitimacy, respectively, in the context of socio-political 
legitimacy 
The legitimation strategies of multinational seed producers and plant protection 
product manufacturers are not uniform, although legitimation, which they hope to realise with 
the help of plant geneticist researchers, and which can be labelled as “legitimacy spill-over”, 
is a common denominator present in all of them. As for the legitimation strategies identified 
in the relevant technical literature, they tend to combine them: the tactical elements of the 
strategies of conformity, compromise, avoidance, opposition and manipulation respectively, 
are present simultaneously. 
 
Scientific vs. lay knowledge and the issue of expert competencies represent a central 
topic of the legitimation arguments. We cannot speak of participatory decision-making in the 
Hungarian legitimation processes, despite the fact that several stakeholder groups were 
represented in the preparation of the legislation which determines the agricultural presence of 
GMOs to a definite extent. 
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